Hikma Pharmaceuticals to invest $1B by 2030 to expand US manufacturing, R&D

view original post

Hikma Pharmaceuticals USA (OTCPK:HKMPF) plans to invest $1 billion through 2030 to boost its U.S. manufacturing and R&D. Under its “America Leans on Hikma” initiative, investment aims to enhance the …